

"A global leader in point of care diagnostic solutions for hemoglobin, glucose and infection testing"
HemoCue provides point of care diagnostic solutions that enable healthcare practitioners to deliver accurate, immediate test results worldwide. The company specialises in hematology, diabetes and infection testing, offering portable systems that produce lab quality results without central laboratory delays. From primary care clinics to emergency departments, blood banks and remote settings, HemoCue devices support faster treatment decisions at the bedside. Founded over 40 years ago, HemoCue performs more than 140 million tests per year across 130 countries. As part of Danaher Corporation, the company serves healthcare providers who need reliable diagnostic data to improve patient outcomes and extend quality care to underserved populations.


430
Team Members
1982
Founded
Diagnostics
Sector
Remote
Work Environment
A world where every healthcare practitioner, regardless of location or resources, has immediate access to accurate diagnostic information that enables the right treatment decision for every patient at the point of care.
Advancing care, test by test, everywhere by providing foundational diagnostic solutions that enable high quality care across clinical settings and geographies.